Skip to Main content Skip to Navigation
Journal articles

Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study

Abstract : Endothelial colony-forming cells (ECFCs) are promising candidates for cell therapy of ischemic diseases, as less than 10% of patients with an ischemic stroke are eligible for thrombolysis. We previously reported that erythropoietin priming of ECFCs increased their in vitro and in vivo angiogenic properties in mice with hindlimb ischemia. The present study used SPECT/CT to evaluate whether priming of ECFCs with erythropoietin could enhance their homing to the ischemic site after transient middle cerebral artery occlusion (MCAO) followed by reperfusion in rats and potentiate their protective or regenerative effect on blood-brain barrier (BBB) disruption, cerebral apoptosis, and cerebral blood flow (CBF).
Document type :
Journal articles
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-01451166
Contributor : Françoise Dignat-George <>
Submitted on : Tuesday, January 31, 2017 - 5:09:21 PM
Last modification on : Wednesday, August 19, 2020 - 12:08:12 PM

Links full text

Identifiers

Collections

Citation

Philippe Garrigue, Guillaume Hache, Youssef Bennis, Pauline Brige, Jimmy Stalin, et al.. Erythropoietin Pretreatment of Transplanted Endothelial Colony-Forming Cells Enhances Recovery in a Cerebral Ischemia Model by Increasing Their Homing Ability: A SPECT/CT Study. Journal of Nuclear Medicine, Society of Nuclear Medicine, 2016, 57 (11), pp.1798-1804. ⟨10.2967/jnumed.115.170308⟩. ⟨hal-01451166⟩

Share

Metrics

Record views

204